APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemorrhagic Septicemia Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Hemorrhagic Septicemia Vaccines Market Analysis and Forecast 2026-2032

22 December 2025202 pages

Choose your research edition.

Industry ResearchHemorrhagic Septicemia Vaccines Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemorrhagic Septicemia Vaccines Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Hemorrhagic Septicemia Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemorrhagic Septicemia Vaccines Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemorrhagic Septicemia Vaccines Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Hemorrhagic Septicemia Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hemorrhagic Septicemia Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Hemorrhagic Septicemia Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Hemorrhagic Septicemia Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Hemorrhagic Septicemia Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Hemorrhagic Septicemia Vaccines include Zoetis, Vecol, National Veterinary Research Institute, Limor de Colombia, Laboratorios Ovejero, Laboratorios Laverlam, LABIOFAM, Intervac (PVT) Ltd and Institute of Veterinary Preventive Medicine, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hemorrhagic Septicemia Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hemorrhagic Septicemia Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Hemorrhagic Septicemia Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hemorrhagic Septicemia Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hemorrhagic Septicemia Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hemorrhagic Septicemia Vaccines sales, projected growth trends, production technology, application and end-user industry.

Hemorrhagic Septicemia Vaccines Segment by Company

Zoetis

Vecol

National Veterinary Research Institute

Limor de Colombia

Laboratorios Ovejero

Laboratorios Laverlam

LABIOFAM

Intervac (PVT) Ltd

Institute of Veterinary Preventive Medicine

Institute of Animal Health and Veterinary Biologicals

Indian Immunologicals Limited

FATRO

Ceva Santé Animale

C.A. Laboratorios Asociados (CALA)

Brilliant Bio Pharma

Bio-Labs (PVT) Limited

Hemorrhagic Septicemia Vaccines Segment by Type

Oil–adjuvant Vaccines

Aluminum hydroxide-adjuvant Vaccines

Hemorrhagic Septicemia Vaccines Segment by Application

Cattle

Buffaloes

Hemorrhagic Septicemia Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemorrhagic Septicemia Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemorrhagic Septicemia Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemorrhagic Septicemia Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hemorrhagic Septicemia Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hemorrhagic Septicemia Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemorrhagic Septicemia Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hemorrhagic Septicemia Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oil–adjuvant Vaccines Major Manufacturers Table 3. Aluminum hydroxide-adjuvant Vaccines Major Manufacturers Table 4. Global Hemorrhagic Septicemia Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cattle Major Manufacturers Table 6. Buffaloes Major Manufacturers Table 7. Hemorrhagic Septicemia Vaccines Industry Trends Table 8. Hemorrhagic Septicemia Vaccines Industry Drivers Table 9. Hemorrhagic Septicemia Vaccines Industry Opportunities and Challenges Table 10. Hemorrhagic Septicemia Vaccines Industry Restraints Table 11. Global Hemorrhagic Septicemia Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Hemorrhagic Septicemia Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Hemorrhagic Septicemia Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Region (2021-2026) Table 15. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Region (2027-2032) Table 16. Global Hemorrhagic Septicemia Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (m units) Table 17. Global Hemorrhagic Septicemia Vaccines Sales by Region (2021-2026) & (m units) Table 18. Global Hemorrhagic Septicemia Vaccines Sales by Region (2027-2032) & (m units) Table 19. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Region (2021-2026) Table 20. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Region (2027-2032) Table 21. Global Hemorrhagic Septicemia Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Hemorrhagic Septicemia Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Manufacturers (2021-2026) Table 25. Global Hemorrhagic Septicemia Vaccines Sales Price (US$/k unit) of Manufacturers (2021-2026) Table 26. Global Hemorrhagic Septicemia Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Hemorrhagic Septicemia Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Hemorrhagic Septicemia Vaccines Manufacturers, Product Type & Application Table 29. Global Hemorrhagic Septicemia Vaccines Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Hemorrhagic Septicemia Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Hemorrhagic Septicemia Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Hemorrhagic Septicemia Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Type (2021-2026) Table 36. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Type (2027-2032) Table 37. Global Hemorrhagic Septicemia Vaccines Sales by Type 2021 VS 2025 VS 2032 (m units) Table 38. Global Hemorrhagic Septicemia Vaccines Sales by Type (2021-2026) & (m units) Table 39. Global Hemorrhagic Septicemia Vaccines Sales by Type (2027-2032) & (m units) Table 40. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Type (2021-2026) Table 41. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Type (2027-2032) Table 42. Global Hemorrhagic Septicemia Vaccines Price by Type (2021-2026) & (US$/k unit) Table 43. Global Hemorrhagic Septicemia Vaccines Price by Type (2027-2032) & (US$/k unit) Table 44. Global Hemorrhagic Septicemia Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Hemorrhagic Septicemia Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Application (2021-2026) Table 48. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Application (2027-2032) Table 49. Global Hemorrhagic Septicemia Vaccines Sales by Application 2021 VS 2025 VS 2032 (m units) Table 50. Global Hemorrhagic Septicemia Vaccines Sales by Application (2021-2026) & (m units) Table 51. Global Hemorrhagic Septicemia Vaccines Sales by Application (2027-2032) & (m units) Table 52. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2021-2026) Table 53. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2027-2032) Table 54. Global Hemorrhagic Septicemia Vaccines Price by Application (2021-2026) & (US$/k unit) Table 55. Global Hemorrhagic Septicemia Vaccines Price by Application (2027-2032) & (US$/k unit) Table 56. Zoetis Company Information Table 57. Zoetis Business Overview Table 58. Zoetis Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 59. Zoetis Hemorrhagic Septicemia Vaccines Product Portfolio Table 60. Zoetis Recent Development Table 61. Vecol Company Information Table 62. Vecol Business Overview Table 63. Vecol Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 64. Vecol Hemorrhagic Septicemia Vaccines Product Portfolio Table 65. Vecol Recent Development Table 66. National Veterinary Research Institute Company Information Table 67. National Veterinary Research Institute Business Overview Table 68. National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 69. National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Product Portfolio Table 70. National Veterinary Research Institute Recent Development Table 71. Limor de Colombia Company Information Table 72. Limor de Colombia Business Overview Table 73. Limor de Colombia Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 74. Limor de Colombia Hemorrhagic Septicemia Vaccines Product Portfolio Table 75. Limor de Colombia Recent Development Table 76. Laboratorios Ovejero Company Information Table 77. Laboratorios Ovejero Business Overview Table 78. Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 79. Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Product Portfolio Table 80. Laboratorios Ovejero Recent Development Table 81. Laboratorios Laverlam Company Information Table 82. Laboratorios Laverlam Business Overview Table 83. Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 84. Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Product Portfolio Table 85. Laboratorios Laverlam Recent Development Table 86. LABIOFAM Company Information Table 87. LABIOFAM Business Overview Table 88. LABIOFAM Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 89. LABIOFAM Hemorrhagic Septicemia Vaccines Product Portfolio Table 90. LABIOFAM Recent Development Table 91. Intervac (PVT) Ltd Company Information Table 92. Intervac (PVT) Ltd Business Overview Table 93. Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 94. Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Product Portfolio Table 95. Intervac (PVT) Ltd Recent Development Table 96. Institute of Veterinary Preventive Medicine Company Information Table 97. Institute of Veterinary Preventive Medicine Business Overview Table 98. Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 99. Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Product Portfolio Table 100. Institute of Veterinary Preventive Medicine Recent Development Table 101. Institute of Animal Health and Veterinary Biologicals Company Information Table 102. Institute of Animal Health and Veterinary Biologicals Business Overview Table 103. Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 104. Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Product Portfolio Table 105. Institute of Animal Health and Veterinary Biologicals Recent Development Table 106. Indian Immunologicals Limited Company Information Table 107. Indian Immunologicals Limited Business Overview Table 108. Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 109. Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Product Portfolio Table 110. Indian Immunologicals Limited Recent Development Table 111. FATRO Company Information Table 112. FATRO Business Overview Table 113. FATRO Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 114. FATRO Hemorrhagic Septicemia Vaccines Product Portfolio Table 115. FATRO Recent Development Table 116. Ceva Santé Animale Company Information Table 117. Ceva Santé Animale Business Overview Table 118. Ceva Santé Animale Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 119. Ceva Santé Animale Hemorrhagic Septicemia Vaccines Product Portfolio Table 120. Ceva Santé Animale Recent Development Table 121. C.A. Laboratorios Asociados (CALA) Company Information Table 122. C.A. Laboratorios Asociados (CALA) Business Overview Table 123. C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 124. C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Product Portfolio Table 125. C.A. Laboratorios Asociados (CALA) Recent Development Table 126. Brilliant Bio Pharma Company Information Table 127. Brilliant Bio Pharma Business Overview Table 128. Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 129. Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Product Portfolio Table 130. Brilliant Bio Pharma Recent Development Table 131. Bio-Labs (PVT) Limited Company Information Table 132. Bio-Labs (PVT) Limited Business Overview Table 133. Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 134. Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Product Portfolio Table 135. Bio-Labs (PVT) Limited Recent Development Table 136. North America Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 137. North America Hemorrhagic Septicemia Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 138. North America Hemorrhagic Septicemia Vaccines Sales by Type (2021-2026) & (m units) Table 139. North America Hemorrhagic Septicemia Vaccines Sales by Type (2027-2032) & (m units) Table 140. North America Hemorrhagic Septicemia Vaccines Sales Price by Type (2021-2026) & (US$/k unit) Table 141. North America Hemorrhagic Septicemia Vaccines Sales Price by Type (2027-2032) & (US$/k unit) Table 142. North America Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 143. North America Hemorrhagic Septicemia Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 144. North America Hemorrhagic Septicemia Vaccines Sales by Application (2021-2026) & (m units) Table 145. North America Hemorrhagic Septicemia Vaccines Sales by Application (2027-2032) & (m units) Table 146. North America Hemorrhagic Septicemia Vaccines Sales Price by Application (2021-2026) & (US$/k unit) Table 147. North America Hemorrhagic Septicemia Vaccines Sales Price by Application (2027-2032) & (US$/k unit) Table 148. North America Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. North America Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. North America Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. North America Hemorrhagic Septicemia Vaccines Sales by Country (2021 VS 2025 VS 2032) & (m units) Table 152. North America Hemorrhagic Septicemia Vaccines Sales by Country (2021-2026) & (m units) Table 153. North America Hemorrhagic Septicemia Vaccines Sales by Country (2027-2032) & (m units) Table 154. North America Hemorrhagic Septicemia Vaccines Sales Price by Country (2021-2026) & (US$/k unit) Table 155. North America Hemorrhagic Septicemia Vaccines Sales Price by Country (2027-2032) & (US$/k unit) Table 156. United States Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 157. Canada Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 158. Mexico Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 159. Europe Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 160. Europe Hemorrhagic Septicemia Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 161. Europe Hemorrhagic Septicemia Vaccines Sales by Type (2021-2026) & (m units) Table 162. Europe Hemorrhagic Septicemia Vaccines Sales by Type (2027-2032) & (m units) Table 163. Europe Hemorrhagic Septicemia Vaccines Sales Price by Type (2021-2026) & (US$/k unit) Table 164. Europe Hemorrhagic Septicemia Vaccines Sales Price by Type (2027-2032) & (US$/k unit) Table 165. Europe Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 166. Europe Hemorrhagic Septicemia Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 167. Europe Hemorrhagic Septicemia Vaccines Sales by Application (2021-2026) & (m units) Table 168. Europe Hemorrhagic Septicemia Vaccines Sales by Application (2027-2032) & (m units) Table 169. Europe Hemorrhagic Septicemia Vaccines Sales Price by Application (2021-2026) & (US$/k unit) Table 170. Europe Hemorrhagic Septicemia Vaccines Sales Price by Application (2027-2032) & (US$/k unit) Table 171. Europe Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Europe Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. Europe Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. Europe Hemorrhagic Septicemia Vaccines Sales by Country (2021 VS 2025 VS 2032) & (m units) Table 175. Europe Hemorrhagic Septicemia Vaccines Sales by Country (2021-2026) & (m units) Table 176. Europe Hemorrhagic Septicemia Vaccines Sales by Country (2027-2032) & (m units) Table 177. Europe Hemorrhagic Septicemia Vaccines Sales Price by Country (2021-2026) & (US$/k unit) Table 178. Europe Hemorrhagic Septicemia Vaccines Sales Price by Country (2027-2032) & (US$/k unit) Table 179. Germany Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 180. France Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 181. U.K. Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 182. Italy Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 183. Russia Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 184. Spain Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 185. Netherlands Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 186. Switzerland Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 187. Sweden Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 188. Poland Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 189. China Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 190. China Hemorrhagic Septicemia Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 191. China Hemorrhagic Septicemia Vaccines Sales by Type (2021-2026) & (m units) Table 192. China Hemorrhagic Septicemia Vaccines Sales by Type (2027-2032) & (m units) Table 193. China Hemorrhagic Septicemia Vaccines Sales Price by Type (2021-2026) & (US$/k unit) Table 194. China Hemorrhagic Septicemia Vaccines Sales Price by Type (2027-2032) & (US$/k unit) Table 195. China Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 196. China Hemorrhagic Septicemia Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 197. China Hemorrhagic Septicemia Vaccines Sales by Application (2021-2026) & (m units) Table 198. China Hemorrhagic Septicemia Vaccines Sales by Application (2027-2032) & (m units) Table 199. China Hemorrhagic Septicemia Vaccines Sales Price by Application (2021-2026) & (US$/k unit) Table 200. China Hemorrhagic Septicemia Vaccines Sales Price by Application (2027-2032) & (US$/k unit) Table 201. Asia Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 202. Asia Hemorrhagic Septicemia Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 203. Asia Hemorrhagic Septicemia Vaccines Sales by Type (2021-2026) & (m units) Table 204. Asia Hemorrhagic Septicemia Vaccines Sales by Type (2027-2032) & (m units) Table 205. Asia Hemorrhagic Septicemia Vaccines Sales Price by Type (2021-2026) & (US$/k unit) Table 206. Asia Hemorrhagic Septicemia Vaccines Sales Price by Type (2027-2032) & (US$/k unit) Table 207. Asia Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 208. Asia Hemorrhagic Septicemia Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 209. Asia Hemorrhagic Septicemia Vaccines Sales by Application (2021-2026) & (m units) Table 210. Asia Hemorrhagic Septicemia Vaccines Sales by Application (2027-2032) & (m units) Table 211. Asia Hemorrhagic Septicemia Vaccines Sales Price by Application (2021-2026) & (US$/k unit) Table 212. Asia Hemorrhagic Septicemia Vaccines Sales Price by Application (2027-2032) & (US$/k unit) Table 213. Asia Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 214. Asia Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 215. Asia Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 216. Asia Hemorrhagic Septicemia Vaccines Sales by Country (2021 VS 2025 VS 2032) & (m units) Table 217. Asia Hemorrhagic Septicemia Vaccines Sales by Country (2021-2026) & (m units) Table 218. Asia Hemorrhagic Septicemia Vaccines Sales by Country (2027-2032) & (m units) Table 219. Asia Hemorrhagic Septicemia Vaccines Sales Price by Country (2021-2026) & (US$/k unit) Table 220. Asia Hemorrhagic Septicemia Vaccines Sales Price by Country (2027-2032) & (US$/k unit) Table 221. Japan Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 222. South Korea Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 223. India Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 224. Australia Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 225. Taiwan Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 226. Southeast Asia Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 227. SAMEA Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 228. SAMEA Hemorrhagic Septicemia Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 229. SAMEA Hemorrhagic Septicemia Vaccines Sales by Type (2021-2026) & (m units) Table 230. SAMEA Hemorrhagic Septicemia Vaccines Sales by Type (2027-2032) & (m units) Table 231. SAMEA Hemorrhagic Septicemia Vaccines Sales Price by Type (2021-2026) & (US$/k unit) Table 232. SAMEA Hemorrhagic Septicemia Vaccines Sales Price by Type (2027-2032) & (US$/k unit) Table 233. SAMEA Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 234. SAMEA Hemorrhagic Septicemia Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 235. SAMEA Hemorrhagic Septicemia Vaccines Sales by Application (2021-2026) & (m units) Table 236. SAMEA Hemorrhagic Septicemia Vaccines Sales by Application (2027-2032) & (m units) Table 237. SAMEA Hemorrhagic Septicemia Vaccines Sales Price by Application (2021-2026) & (US$/k unit) Table 238. SAMEA Hemorrhagic Septicemia Vaccines Sales Price by Application (2027-2032) & (US$/k unit) Table 239. SAMEA Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 240. SAMEA Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 241. SAMEA Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 242. SAMEA Hemorrhagic Septicemia Vaccines Sales by Country (2021 VS 2025 VS 2032) & (m units) Table 243. SAMEA Hemorrhagic Septicemia Vaccines Sales by Country (2021-2026) & (m units) Table 244. SAMEA Hemorrhagic Septicemia Vaccines Sales by Country (2027-2032) & (m units) Table 245. SAMEA Hemorrhagic Septicemia Vaccines Sales Price by Country (2021-2026) & (US$/k unit) Table 246. SAMEA Hemorrhagic Septicemia Vaccines Sales Price by Country (2027-2032) & (US$/k unit) Table 247. Brazil Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 248. Argentina Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 249. Chile Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 250. Colombia Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 251. Peru Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 252. Saudi Arabia Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 253. Israel Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 254. UAE Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 255. Turkey Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 256. Iran Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 257. Egypt Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Table 258. Key Raw Materials Table 259. Raw Materials Key Suppliers Table 260. Hemorrhagic Septicemia Vaccines Distributors List Table 261. Hemorrhagic Septicemia Vaccines Customers List Table 262. Research Programs/Design for This Report Table 263. Authors List of This Report Table 264. Secondary Sources Table 265. Primary Sources List of Figures Figure 1. Hemorrhagic Septicemia Vaccines Image Figure 2. Global Hemorrhagic Septicemia Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemorrhagic Septicemia Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oil–adjuvant Vaccines Image Figure 5. Aluminum hydroxide-adjuvant Vaccines Image Figure 6. Global Hemorrhagic Septicemia Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Hemorrhagic Septicemia Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cattle Image Figure 9. Buffaloes Image Figure 10. Global Hemorrhagic Septicemia Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Figure 12. Global Hemorrhagic Septicemia Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Region (2021-2032) Figure 15. Global Hemorrhagic Septicemia Vaccines Sales (2021-2032) & (m units) Figure 16. Global Hemorrhagic Septicemia Vaccines Sales by Region: 2021 VS 2025 VS 2032 (m units) Figure 17. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Hemorrhagic Septicemia Vaccines Sales YoY (2021-2032) & (m units) Figure 19. Europe Hemorrhagic Septicemia Vaccines Sales YoY (2021-2032) & (m units) Figure 20. China Hemorrhagic Septicemia Vaccines Sales YoY (2021-2032) & (m units) Figure 21. Asia (Excluding China) Hemorrhagic Septicemia Vaccines Sales YoY (2021-2032) & (m units) Figure 22. South America, Middle East and Africa Hemorrhagic Septicemia Vaccines Sales YoY (2021-2032) & (m units) Figure 23. Global Hemorrhagic Septicemia Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Hemorrhagic Septicemia Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Hemorrhagic Septicemia Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Type (2021-2032) Figure 29. Global Hemorrhagic Septicemia Vaccines Sales by Type (2021 VS 2025 VS 2032) & (m units) Figure 30. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Type (2021-2032) Figure 32. Global Hemorrhagic Septicemia Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Application (2021-2032) Figure 35. Global Hemorrhagic Septicemia Vaccines Sales by Application (2021 VS 2025 VS 2032) & (m units) Figure 36. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2021-2032) Figure 38. North America Hemorrhagic Septicemia Vaccines Revenue Share by Type (2021-2032) Figure 39. North America Hemorrhagic Septicemia Vaccines Sales Share by Type (2021-2032) Figure 40. North America Hemorrhagic Septicemia Vaccines Revenue Share by Application (2021-2032) Figure 41. North America Hemorrhagic Septicemia Vaccines Sales Share by Application (2021-2032) Figure 42. North America Hemorrhagic Septicemia Vaccines Revenue Share by Country (2021-2032) Figure 43. North America Hemorrhagic Septicemia Vaccines Sales Share by Country (2021-2032) Figure 44. Europe Hemorrhagic Septicemia Vaccines Revenue Share by Type (2021-2032) Figure 45. Europe Hemorrhagic Septicemia Vaccines Sales Share by Type (2021-2032) Figure 46. Europe Hemorrhagic Septicemia Vaccines Revenue Share by Application (2021-2032) Figure 47. Europe Hemorrhagic Septicemia Vaccines Sales Share by Application (2021-2032) Figure 48. Europe Hemorrhagic Septicemia Vaccines Revenue Share by Country (2021-2032) Figure 49. Europe Hemorrhagic Septicemia Vaccines Sales Share by Country (2021-2032) Figure 50. China Hemorrhagic Septicemia Vaccines Revenue Share by Type (2021-2032) Figure 51. China Hemorrhagic Septicemia Vaccines Sales Share by Type (2021-2032) Figure 52. China Hemorrhagic Septicemia Vaccines Revenue Share by Application (2021-2032) Figure 53. China Hemorrhagic Septicemia Vaccines Sales Share by Application (2021-2032) Figure 54. Asia Hemorrhagic Septicemia Vaccines Revenue Share by Type (2021-2032) Figure 55. Asia Hemorrhagic Septicemia Vaccines Sales Share by Type (2021-2032) Figure 56. Asia Hemorrhagic Septicemia Vaccines Revenue Share by Application (2021-2032) Figure 57. Asia Hemorrhagic Septicemia Vaccines Sales Share by Application (2021-2032) Figure 58. Asia Hemorrhagic Septicemia Vaccines Revenue Share by Country (2021-2032) Figure 59. Asia Hemorrhagic Septicemia Vaccines Sales Share by Country (2021-2032) Figure 60. SAMEA Hemorrhagic Septicemia Vaccines Revenue Share by Type (2021-2032) Figure 61. SAMEA Hemorrhagic Septicemia Vaccines Sales Share by Type (2021-2032) Figure 62. SAMEA Hemorrhagic Septicemia Vaccines Revenue Share by Application (2021-2032) Figure 63. SAMEA Hemorrhagic Septicemia Vaccines Sales Share by Application (2021-2032) Figure 64. SAMEA Hemorrhagic Septicemia Vaccines Revenue Share by Country (2021-2032) Figure 65. SAMEA Hemorrhagic Septicemia Vaccines Sales Share by Country (2021-2032) Figure 66. Hemorrhagic Septicemia Vaccines Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Hemorrhagic Septicemia Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oil–adjuvant Vaccines
  • Aluminum hydroxide-adjuvant Vaccines
Applications
  • Cattle
  • Buffaloes
Companies covered
  • Zoetis
  • Vecol
  • National Veterinary Research Institute
  • Limor de Colombia
  • Laboratorios Ovejero
  • Laboratorios Laverlam
  • LABIOFAM
  • Intervac (PVT) Ltd
  • Institute of Veterinary Preventive Medicine
  • Institute of Animal Health and Veterinary Biologicals
  • Indian Immunologicals Limited
  • FATRO
  • Ceva Santé Animale
  • C.A. Laboratorios Asociados (CALA)
  • Brilliant Bio Pharma
  • Bio-Labs (PVT) Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hemorrhagic Septicemia Vaccines Market by Type
  3. 1.2.1 Global Hemorrhagic Septicemia Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oil–adjuvant Vaccines
  5. 1.2.3 Aluminum hydroxide-adjuvant Vaccines
  6. 1.3 Hemorrhagic Septicemia Vaccines Market by Application
  7. 1.3.1 Global Hemorrhagic Septicemia Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cattle
  9. 1.3.3 Buffaloes
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Hemorrhagic Septicemia Vaccines Market Dynamics
  1. 2.1 Hemorrhagic Septicemia Vaccines Industry Trends
  2. 2.2 Hemorrhagic Septicemia Vaccines Industry Drivers
  3. 2.3 Hemorrhagic Septicemia Vaccines Industry Opportunities and Challenges
  4. 2.4 Hemorrhagic Septicemia Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hemorrhagic Septicemia Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hemorrhagic Septicemia Vaccines Revenue by Region
  3. 3.2.1 Global Hemorrhagic Septicemia Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hemorrhagic Septicemia Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Hemorrhagic Septicemia Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hemorrhagic Septicemia Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hemorrhagic Septicemia Vaccines Sales by Region
  9. 3.4.1 Global Hemorrhagic Septicemia Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hemorrhagic Septicemia Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Hemorrhagic Septicemia Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Hemorrhagic Septicemia Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hemorrhagic Septicemia Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Hemorrhagic Septicemia Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hemorrhagic Septicemia Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hemorrhagic Septicemia Vaccines Sales by Manufacturers
  6. 4.2.1 Global Hemorrhagic Septicemia Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hemorrhagic Septicemia Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hemorrhagic Septicemia Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hemorrhagic Septicemia Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hemorrhagic Septicemia Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hemorrhagic Septicemia Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hemorrhagic Septicemia Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Hemorrhagic Septicemia Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hemorrhagic Septicemia Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Hemorrhagic Septicemia Vaccines Tier 1, Tier 2, and Tier 3
5 Hemorrhagic Septicemia Vaccines Market by Type
  1. 5.1 Global Hemorrhagic Septicemia Vaccines Revenue by Type
  2. 5.1.1 Global Hemorrhagic Septicemia Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hemorrhagic Septicemia Vaccines Sales by Type
  6. 5.2.1 Global Hemorrhagic Septicemia Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hemorrhagic Septicemia Vaccines Sales by Type (2021-2032) & (m units)
  8. 5.2.3 Global Hemorrhagic Septicemia Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hemorrhagic Septicemia Vaccines Price by Type
6 Hemorrhagic Septicemia Vaccines Market by Application
  1. 6.1 Global Hemorrhagic Septicemia Vaccines Revenue by Application
  2. 6.1.1 Global Hemorrhagic Septicemia Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hemorrhagic Septicemia Vaccines Sales by Application
  6. 6.2.1 Global Hemorrhagic Septicemia Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hemorrhagic Septicemia Vaccines Sales by Application (2021-2032) & (m units)
  8. 6.2.3 Global Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hemorrhagic Septicemia Vaccines Price by Application
7 Company Profiles
  1. 7.1 Zoetis
  2. 7.1.1 Zoetis Company Information
  3. 7.1.2 Zoetis Business Overview
  4. 7.1.3 Zoetis Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Hemorrhagic Septicemia Vaccines Product Portfolio
  6. 7.1.5 Zoetis Recent Developments
  7. 7.2 Vecol
  8. 7.2.1 Vecol Company Information
  9. 7.2.2 Vecol Business Overview
  10. 7.2.3 Vecol Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Vecol Hemorrhagic Septicemia Vaccines Product Portfolio
  12. 7.2.5 Vecol Recent Developments
  13. 7.3 National Veterinary Research Institute
  14. 7.3.1 National Veterinary Research Institute Company Information
  15. 7.3.2 National Veterinary Research Institute Business Overview
  16. 7.3.3 National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Product Portfolio
  18. 7.3.5 National Veterinary Research Institute Recent Developments
  19. 7.4 Limor de Colombia
  20. 7.4.1 Limor de Colombia Company Information
  21. 7.4.2 Limor de Colombia Business Overview
  22. 7.4.3 Limor de Colombia Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Limor de Colombia Hemorrhagic Septicemia Vaccines Product Portfolio
  24. 7.4.5 Limor de Colombia Recent Developments
  25. 7.5 Laboratorios Ovejero
  26. 7.5.1 Laboratorios Ovejero Company Information
  27. 7.5.2 Laboratorios Ovejero Business Overview
  28. 7.5.3 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Product Portfolio
  30. 7.5.5 Laboratorios Ovejero Recent Developments
  31. 7.6 Laboratorios Laverlam
  32. 7.6.1 Laboratorios Laverlam Company Information
  33. 7.6.2 Laboratorios Laverlam Business Overview
  34. 7.6.3 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Product Portfolio
  36. 7.6.5 Laboratorios Laverlam Recent Developments
  37. 7.7 LABIOFAM
  38. 7.7.1 LABIOFAM Company Information
  39. 7.7.2 LABIOFAM Business Overview
  40. 7.7.3 LABIOFAM Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 LABIOFAM Hemorrhagic Septicemia Vaccines Product Portfolio
  42. 7.7.5 LABIOFAM Recent Developments
  43. 7.8 Intervac (PVT) Ltd
  44. 7.8.1 Intervac (PVT) Ltd Company Information
  45. 7.8.2 Intervac (PVT) Ltd Business Overview
  46. 7.8.3 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Product Portfolio
  48. 7.8.5 Intervac (PVT) Ltd Recent Developments
  49. 7.9 Institute of Veterinary Preventive Medicine
  50. 7.9.1 Institute of Veterinary Preventive Medicine Company Information
  51. 7.9.2 Institute of Veterinary Preventive Medicine Business Overview
  52. 7.9.3 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Product Portfolio
  54. 7.9.5 Institute of Veterinary Preventive Medicine Recent Developments
  55. 7.10 Institute of Animal Health and Veterinary Biologicals
  56. 7.10.1 Institute of Animal Health and Veterinary Biologicals Company Information
  57. 7.10.2 Institute of Animal Health and Veterinary Biologicals Business Overview
  58. 7.10.3 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Product Portfolio
  60. 7.10.5 Institute of Animal Health and Veterinary Biologicals Recent Developments
  61. 7.11 Indian Immunologicals Limited
  62. 7.11.1 Indian Immunologicals Limited Company Information
  63. 7.11.2 Indian Immunologicals Limited Business Overview
  64. 7.11.3 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Product Portfolio
  66. 7.11.5 Indian Immunologicals Limited Recent Developments
  67. 7.12 FATRO
  68. 7.12.1 FATRO Company Information
  69. 7.12.2 FATRO Business Overview
  70. 7.12.3 FATRO Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 FATRO Hemorrhagic Septicemia Vaccines Product Portfolio
  72. 7.12.5 FATRO Recent Developments
  73. 7.13 Ceva Santé Animale
  74. 7.13.1 Ceva Santé Animale Company Information
  75. 7.13.2 Ceva Santé Animale Business Overview
  76. 7.13.3 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Product Portfolio
  78. 7.13.5 Ceva Santé Animale Recent Developments
  79. 7.14 C.A. Laboratorios Asociados (CALA)
  80. 7.14.1 C.A. Laboratorios Asociados (CALA) Company Information
  81. 7.14.2 C.A. Laboratorios Asociados (CALA) Business Overview
  82. 7.14.3 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Product Portfolio
  84. 7.14.5 C.A. Laboratorios Asociados (CALA) Recent Developments
  85. 7.15 Brilliant Bio Pharma
  86. 7.15.1 Brilliant Bio Pharma Company Information
  87. 7.15.2 Brilliant Bio Pharma Business Overview
  88. 7.15.3 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Product Portfolio
  90. 7.15.5 Brilliant Bio Pharma Recent Developments
  91. 7.16 Bio-Labs (PVT) Limited
  92. 7.16.1 Bio-Labs (PVT) Limited Company Information
  93. 7.16.2 Bio-Labs (PVT) Limited Business Overview
  94. 7.16.3 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Product Portfolio
  96. 7.16.5 Bio-Labs (PVT) Limited Recent Developments
8 North America
  1. 8.1 North America Hemorrhagic Septicemia Vaccines Market Size by Type
  2. 8.1.1 North America Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Hemorrhagic Septicemia Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Hemorrhagic Septicemia Vaccines Price by Type (2021-2032)
  5. 8.2 North America Hemorrhagic Septicemia Vaccines Market Size by Application
  6. 8.2.1 North America Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Hemorrhagic Septicemia Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Hemorrhagic Septicemia Vaccines Price by Application (2021-2032)
  9. 8.3 North America Hemorrhagic Septicemia Vaccines Market Size by Country
  10. 8.3.1 North America Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hemorrhagic Septicemia Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hemorrhagic Septicemia Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Hemorrhagic Septicemia Vaccines Market Size by Type
  2. 9.1.1 Europe Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hemorrhagic Septicemia Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Hemorrhagic Septicemia Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Hemorrhagic Septicemia Vaccines Market Size by Application
  6. 9.2.1 Europe Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hemorrhagic Septicemia Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Hemorrhagic Septicemia Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Hemorrhagic Septicemia Vaccines Market Size by Country
  10. 9.3.1 Europe Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hemorrhagic Septicemia Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hemorrhagic Septicemia Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Hemorrhagic Septicemia Vaccines Market Size by Type
  2. 10.1.1 China Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Hemorrhagic Septicemia Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Hemorrhagic Septicemia Vaccines Price by Type (2021-2032)
  5. 10.2 China Hemorrhagic Septicemia Vaccines Market Size by Application
  6. 10.2.1 China Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Hemorrhagic Septicemia Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Hemorrhagic Septicemia Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hemorrhagic Septicemia Vaccines Market Size by Type
  2. 11.1.1 Asia Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hemorrhagic Septicemia Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Hemorrhagic Septicemia Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Hemorrhagic Septicemia Vaccines Market Size by Application
  6. 11.2.1 Asia Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hemorrhagic Septicemia Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Hemorrhagic Septicemia Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Hemorrhagic Septicemia Vaccines Market Size by Country
  10. 11.3.1 Asia Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hemorrhagic Septicemia Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hemorrhagic Septicemia Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hemorrhagic Septicemia Vaccines Market Size by Type
  2. 12.1.1 SAMEA Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hemorrhagic Septicemia Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hemorrhagic Septicemia Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Hemorrhagic Septicemia Vaccines Market Size by Application
  6. 12.2.1 SAMEA Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hemorrhagic Septicemia Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hemorrhagic Septicemia Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Hemorrhagic Septicemia Vaccines Market Size by Country
  10. 12.3.1 SAMEA Hemorrhagic Septicemia Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hemorrhagic Septicemia Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hemorrhagic Septicemia Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hemorrhagic Septicemia Vaccines Value Chain Analysis
  2. 13.1.1 Hemorrhagic Septicemia Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hemorrhagic Septicemia Vaccines Production Mode & Process
  6. 13.2 Hemorrhagic Septicemia Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hemorrhagic Septicemia Vaccines Distributors
  9. 13.2.3 Hemorrhagic Septicemia Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst